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Abstract:  Microarray technology allows molecular classification of tumors and 
identification of tumor markers, and it has been used widely in the field of cancer research. 
Although the problem of binary tumor classification has been addressed extensively, it lacks 
in-depth research on multi-category tumor classification. In this paper, informative gene 
selection method, which is a critical step of multi-category tumor classification, was studied. 
We present a hybrid gene selection strategy aiming to take advantage from the combination 
of different gene selection algorithms. Top ranked genes of Chi-squared and SVM-RFE 
algorithms are fused to generate a gene pool, and a genetic algorithm further explores the 
search space for reduced gene subsets. We tested the proposed model on the multi-category 
lung cancer microarray gene expression data set. Compared with each individual gene 
selection algorithm, our hybrid model was able to obtain highest classification performance 
with much smaller sized subsets of informative genes. 
 
Keywords:  Multi-category tumor classification, Gene selection, Hybrid model, Genetic 
algorithm, Microarray data. 
 
Introduction 
Over the last few years, microarray technology has been used extensively in the field of 
cancer research, and it allows molecular classification of tumors and identification of tumor 
markers, according to their gene expression profiles [4]. Microarrays can simultaneously 
measure the expression level of thousands of genes, providing a high-throughput and 
systematic research platform in cancer research. However, microarrays contain a larger 
number of genes (generally greater than 10 000), and a smaller sample size (generally less 
than 100), therefore, it is a critical issue to select a small number of informative genes from 
thousands of genes for accurate classification [12]. The objective of gene selection is to 
eliminate noisy and redundant genes, reduce the calculation burden in subsequent 
classification task and improve the prediction performance of learning model. In addition, an 
optimal smaller subset of genes may contain biomarkers, which could be more convenient for 
verification in the subsequent molecular biological experiments, and thus allow for a better 
understanding of the molecular mechanisms of tumor development [5]. 
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The problem of binary tumor classification (the class number of tumors is 2, for example, 
classification between tumor and normal tissue samples) has been studied extensively, and 
achieved satisfactory results [18]. However, for multi-category tumor classification (the class 
number of tumors is more than 2), it is lack of in-depth research, the classification accuracy is 
low in the overall published literature, and the classification accuracy decreases greatly as the 
tumor category number increases [13, 18].  
 
A few new approaches have been proposed for multi-category tumor classification. Liu et al. 
[14] proposed to combine genetic algorithm (GA) and all paired support vector machine 
(SVM) methods for multiclass cancer classification. Zhou et al. [20] proposed the   
MSVM-RFE algorithms, which are four expansions of the well-known SVM method based 
on recursive feature elimination (SVM-RFE) algorithm. Wang et al. [18] reported a Chi-
square-statistic-based Top Scoring Genes (Chi-TSG) classifier for informative gene selection 
and multi-class cancer classification. However, it is possible to obtain higher classification 
accuracy when choosing fewer genes by using more powerful dada mining algorithms.  
 
In this paper, a hybrid gene selection method is presented for multi-category tumor 
classification on microarray data. Section 2 introduces the proposed hybrid model. The 
experimental analysis is presented in Section 3. Conclusions are drawn in Section 4. 
 
The hybrid model 
There are three common methods to gene selection [16]: filter, wrapper and embedded 
methods. Filter method is independent of the classifiers, despite its computationally simple 
and fast, it also has several shortcomings: firstly, it ignores the interaction with the classifiers. 
Secondly, many filter algorithms are univariate, and ignore the dependency between genes. 
Wrapper method has advantages over filter method which are the interaction between genes 
and classifiers, and the ability to take into account gene dependencies. However, its 
computational cost is relatively high, and the selected gene subset has a higher risk of over-
fitting [10]. Embedded method takes into account the internal characteristics of the classifier 
(such as support vectors in support vector machine classifier). It is able to obtain a high 
accuracy by coupling with the classifier, but its performance depends greatly on the classifier, 
and the adaptability of the learning model need to be validated on the other classifiers. The 
SVM-RFE algorithm is one example of embedded method [6]. 
 
These limitations advise us to propose a hybrid method [15, 19] that aims at taking advantage 
from the combination of different types of algorithms. The proposed hybrid model can be 
illustrated as follows: In the first step, m ( ) gene selection criteria are applied on initial 
microarray dataset to generate m different ranked gene lists; In the second step, for each 
ranked gene set, n top ranked genes from m different ranked gene list are input into the gene 
pool, each gene pool is further evaluated by a genetic algorithm that could search an optimal 
subset with smaller size and better classification performance. 
2 ≥ m
 
Most of genes detected in microarray are irrelevant to classification. In the first step, a 
particular ranking criterion is used to evaluate individual genes, and each gene is assigned a 
score according to its relevance to the target class. An ordered gene list is generated, and the 
genes are listed in descending order of relevance. A gene with a high ranking score indicates 
that the gene contains information potentially useful for classification.  
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In this study, two different types of gene selection algorithms (i.e. Chi-squared, SVM-RFE) 
are used. In particular, Chi-squared algorithm is a type of filter method, whereas SVM-RFE is 
an embedded method. Their definitions are briefly stated below. 
 
Chi-squared method 
The Chi-squared method evaluates ranking scores of each individual gene by measuring the 
Chi-squared statistics ( ) with respect to the classes [8]. The   value of each gene is 
calculated as 
2 χ
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where   is the total number of patterns in the i-th interval, j-th class,   is the expected 
frequency of  ,   is the number of intervals, and n is the number of classes. 
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SVM-RFE method 
SVM-RFE method removes recursively the genes that are of least significance to the classifier 
from the gene set [6]. The significance of each gene to the classifier is defined by the sum 
square of the weight vector w, which is calculated as 
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where  i α  is estimated from the training set,  [1 , 1 ] i y ∈ −+ is the class label of sample i, and  
 is the gene expression vector of a sample i in the training set. The training vectors with 
non-zero 
i x
i α  are support vectors [12]. 
 
In the second step, n top ranked genes are selected from each ranked gene lists, and it is 
important to set an appropriate threshold to retain only the informative genes. Since the choice 
of n is somewhat arbitrary for the filter method, several parameters n for choosing top n 
ranked genes are thus used. Genes selected from multiple gene selection algorithms are then 
input into the gene pool. 
 
Filter algorithms often do not take into account the correlation between genes, and the gene 
pool may contain redundant genes. A genetic algorithm is applied to find a gene subset 
including sufficient classification information as possible, but involving fewer genes. GA is a 
heuristic search method which mimics the process of natural selection in computer [3, 17].  
A genetic algorithm simulates the ways in which organisms adapt to natural environment, and 
the search space is mapped to the genetic space. A possible solution (called individual) to 
each problem is encoded as a binary string, and a set of individuals is called population. 
 
A GA starts from a population of randomly generated individuals, evaluates the fitness of 
every individual in the population. The more fitted individuals are retained in the current 
population, and each individual is modified to form a new generation. A GA is an iterative 
process which evolves toward better solutions until it meets certain predetermined 
optimization targets. 
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The basic components of our GA are described as follows: 
•  Representation of individual 
Each individual is encoded by n-bit binary strings, where the bit “1” represents the 
corresponding gene in the subset being selected, while the bit “0” means the opposite. 
•  Fitness function 
Our genetic algorithm is designed to minimize classification error rate of the chosen 
classifier. Each individual in a population is evaluated by the classification error rate 
of a SVM classifier, i.e., SMO (sequential minimal optimization algorithm) classifier 
in WEKA [7]. 
•  Genetic operators 
Roulette wheel selection is used as selection operator, single-point crossover is used as 
crossover operator, and bit flip mutation is used as mutation operator. 
 
Experimental results 
Data set 
The lung cancer data set [1] was used to validate the proposed model, the data set was 
downloaded from the website: http://www.pnas.org/content/98/24/13790/suppl/DC1.  
This data set is a multi-class tumor gene expression data set, which contains a total of 203 
samples and six categories (i.e., 4 subtypes of lung cancer, 1 subtype of extrapulmonary 
metastasis and 1 subtype of normal tissue). The 203 samples include histologically defined 
lung adenocarcinomas (n = 127), squamous cell lung carcinomas (n = 21), pulmonary 
carcinoids (n = 20), SCLC (n = 6) cases, and normal lung (n = 17) tissues. The other   
12 specimen suspected to be extrapulmonary metastases were not included in this experiment. 
Each sample contains 12 600 gene expression values. 
 
Experimental platform 
The experimental data preprocessing was divided into two steps: removal of housekeeping 
genes and normalization. After removal of the housekeeping gene, 12,533 gene expression 
values of each sample remained. The gene expression values are normalized so that the gene 
expression value of each sample has a mean of 0 and a standard deviation of 1. 
 
The experiments were carried out by using the WEKA [7] (http://www.cs.waikato.ac.nz/ 
ml/weka/) platform, which provides a variety of gene selection algorithms as well as the 
genetic search and the classification model. The SMO classifier was used to perform the 
classification task. The SMO classifier contains 4 kinds of kernel functions, including 
NormalizedPolyKernel, PolyKernel, RBFKernel and StringKernel, and the polynomial kernel 
function (PolyKernel) was selected. The optimal adjustment of parameters in training SVM 
classifier is very time-consuming, and the parameters were specified in a fixed manner 
hereby. Since the data was already normalized, the “FilterType” parameter was set to 
“standardize training data” option. The penalty parameter C was set to 100. The 10-fold cross-
validation was used to evaluate the performance of a SMO classifier. In the 10-fold cross-
validation, the data is randomly partitioned into 10 subsets of (approximately) equal size.  
The classifier is trained 10 times, each time 9 subsets are used as training data, and a single 
subset is retained as the validation data for computing the classification accuracy. The 10 
results from the folds are then averaged. 
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The GA parameters used in our experiment were set as follows:  
•  probability of crossover = 1,  
•  probability of mutation = 0.02,  
•  number of generations = 50,  
•  population size = 30.  
 
In fitness evaluation, classification error rate was performed by a 10-fold cross-validation for 
SMO classifiers. 
 
Experimental results 
Both the Chi-squared and SVM-RFE algorithms generate a gene list where the gene scores 
rank from high to low, and subsets of top n genes were used to assess the performance of the 
classifiers. As shown in Table 1, in general, SVM-RFE gives better performance, and it 
achieves 100% accuracy with 30 genes. It is because SVM-RFE is an embedded method, and 
it has a good coupling with SVM classifier. 
 
Table 1. 10-fold accuracy of Chi-squared and  
SVM-RFE algorithms on lung cancer data set 
Top n genes  Chi-squared (%) SVM-RFE (%) 
10 83.77 95.81 
20 82.72 97.91 
30 90.58 100.00 
50 92.15 99.48 
100 94.76 100.00 
200 95.29  99.48 
500 96.34  99.48 
1000 96.86  98.95 
2000 97.38  98.43 
5000 96.86  97.91 
12533 94.24  94.24 
 
To validate our proposed hybrid model, we tested several gene pools, each of which contains 
a different number of top n genes chosen from the Chi-squared and SVM-RFE algorithms, 
where n is set to 10, 20, 30, 50 and 100. As the genetic algorithm is a stochastic search 
method, 10 trials were performed on each gene pool, and the results were averaged.   
The top-20 genes given by the two algorithms are shown in Table 2, and the only overlapped 
gene is VAMP2.  
 
As shown in Table 3, when top-20 genes were searched, the genetic algorithm was capable of 
finding smallest size of subset and achieves 100% classification accuracy. The average subset 
size of 14.6 genes is much less than SVM-RFE method while it needs 30 genes to obtain the 
same accuracy. 
 
All of the 10 subsets selected from the gene pool of top-20 genes achieve 100% accuracy, and 
3 subsets out of 10 contain minimum number of genes (n = 13). The selected genes of the 
minimum subsets are shown in Table 4.  
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Table 2. Top-20 genes selected from the Chi-squared and  
SVM-RFE algorithms (the word in parentheses is probe ID) 
Gene selection 
algorithms  Top-20 genes 
Chi-squared 
VAMP2(32254_at), SFN (33322_i_at),  
CHGB (33426_at), SCG5 (34265_at),  
PAR-SN /// SNORD107 /// SNRPN ///  
SNURF (34842_at), NOS1AP (35531_at),  
APLP1 (36148_at), PTPRN2 (36160_s_at),  
SCG2 (36924_r_at), SYP (37182_at),  
INA (37210_at), MAPRE2 (37406_at),  
SCAMP5 (37545_at), SV2A (38032_at),  
S100A11 (38138_at), PSD (38174_at),  
SNAP25 (38484_at), TERF2IP (38982_at),  
CHGA (40808_at), KCNK3 (41325_at) 
SVM-RFE 
SMAD6 (1955_s_at), ERBB3 (2089_s_at),  
NDUFS7 (31638_at), FXYD1 (32109_at),  
VAMP2 (32254_at), ADH7 (33529_at),  
SH3BP1 (34046_at), PNPLA6 (34874_at),  
PCYT1B (35552_at), DSP (36133_at),  
BRD2 (36209_at), CBX7 (36894_at),  
TUBA3C /// TUBA3D (38350_f_at),  
EMP3 (39182_at), KCND3 (39266_at),  
ISL1 (39990_at), UBE2S (40619_at),  
MAPRE3 (40825_at), HMGN2 (41231_f_at),  
FKBP1A (880_at) 
 
 
Table 3. 10-fold accuracy of the proposed model on lung cancer data set 
Top n genes  Average accuracy (%) Average subset size 
10 98.00  9.60 
20 100.00  14.60 
30 100.00  17.30 
50 100.00  27.00 
100 100.00  57.30 
 
 
The genes with star (*) are selected from the SVM-RFE method, and the other genes are 
chosen from the Chi-squared method. The minimum informative gene subsets are combined 
by the genes from multiple outcomes of gene ranking algorithms. It is observed that 6 genes 
of SMAD6, FXYD1, ADH7, PCYT1B, HMGN2, and FKBP1A are picked in all of the three 
trials. Out of the 6 genes, SMAD family member 6 (SMAD6) [9], and high mobility group 
nucleosomal binding domain 2 (HMGN2) [2] were reported to be associated with lung cancer. 
SMAD 6 is a member of SMAD family of proteins, and it plays a role in BMP and TGF-beta 
signaling pathway. High expression of SMAD6 was reported to be associated with a reduced 
survival in lung cancer patients [9]. HMGN2 is probably involved in control of chromatin 
structure and transcription. Recently, microarray analyses suggested that HMGN2 acts as a 
positive modulator of nuclear factor κB signaling pathway in lung cancer cells [2].   INT. J. BIOAUTOMATION, 2013, 17(4), 249-258 
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Table 4. The selected genes of the minimum subset on lung cancer data set  
(the word in parentheses is probe ID) 
Trials Selected  genes 
1 
SMAD6 (1955_s_at)*, ERBB3 (2089_s_at)*,  
FXYD1 (32109_at)*, CHGB (33426_at),  
ADH7 (33529_at)*, SH3BP1 (34046_at)*,  
PCYT1B (35552_at)*, DSP (36133_at)*,  
MAPRE2 (37406_at), KCND3 (39266_at)*,  
MAPRE3(40825_at)*, HMGN2(41231_f_at)*,  
FKBP1A(880_at)* 
2 
SMAD6 (1955_s_at)*, NDUFS7 (31638_at)*,  
FXYD1 (32109_at)*, ADH7 (33529_at)*,  
PNPLA6 (34874_at)*, PCYT1B (35552_at)*,  
BRD2 (36209_at)*, INA (37210_at),  
SCAMP5 (37545_at), S100A11 (38138_at),  
KCND3 (39266_at)*, HMGN2 (41231_f_at)*,  
FKBP1A (880_at)* 
3 
SMAD6 (1955_s_at)*, ERBB3 (2089_s_at)*,  
FXYD1 (32109_at)*, ADH7 (33529_at)*,  
PNPLA6 (34874_at)*, PCYT1B (35552_at)*,  
APLP1 (36148_at), BRD2 (36209_at)*,  
MAPRE2 (37406_at), PSD (38174_at),  
TUBA3C /// TUBA3D (38350_f_at)*,  
HMGN2 (41231_f_at)*, FKBP1A (880_at)* 
 
 
Conclusions 
In recent years a remarkable progress has been seen in the use of high-throughput techniques 
such as microarrays for molecular classification of tumors. The development, invasion and 
metastasis of tumor is a multi-stage, multi-gene regulated, multi-pathway process [11] which 
results in tumor heterogeneity and multi-category subtypes of tumors. The problem of multi-
category tumor classification remains a challenge in the field of machine learning. 
 
In this paper, we present a hybrid feature selection model for gene expression-based multi-
category tumor classification. Genes from multiple outcomes of gene ranking algorithms are 
combined, and a genetic algorithm is applied to search an optimal subset. Compared with 
each individual ranking gene selection algorithm, our hybrid model is capable of finding 
much smaller sized subsets of informative genes and obtaining highest classification 
performance. We leave for future work the investigation of combining additional gene 
ranking algorithms, as well as the other state of the art classifiers. 
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